Doctors Recommend A New Treatment For Cancer.
The remedy Arimidex reduces the imperil of developing breast cancer by more than 50 percent among postmenopausal women at tainted risk for the disease, according to a new study Dec 2013. The finding, scheduled for appearance Thursday at the San Antonio Breast Cancer Symposium in Texas, adds count that Arimidex (anastrozole) might be a valuable new preventive option for some women. The study will also be published in the journal The Lancet.
So "Two other antihormone therapies, tamoxifen and raloxifene, are in use by some women to prevent breast cancer, but these drugs are not as effective and can have adverse side effects, which determine their use," study lead author Jack Cuzick said in a new release from the American Association for Cancer Research. "Hopefully, our findings will outstrip to an alternative prevention therapy with fewer string effects for postmenopausal women at high risk for developing breast cancer," said Cuzick, climax of the Cancer Research UK Centre for Cancer Prevention and director of the Wolfson Institute of Preventive Medicine at Queen Mary University of London.
About 80 percent of US bust cancer patients have tumors with expensive levels of hormone receptors, and these tumors are fueled by the hormone estrogen. Arimidex prevents the body from making estrogen and is therefore cast-off to treat postmenopausal women with hormone receptor-positive titty cancer. The study included more than 3800 postmenopausal women at increased endanger for breast cancer due to having two or more blood relatives with breast cancer, having a innate or sister who developed breast cancer before age 50, or having a nourish or sister who had breast cancer in both breasts.